» Articles » PMID: 38467667

Serum Uric Acid Levels and Prognosis of Patients with Non-alcoholic Fatty Liver Disease

Overview
Journal Sci Rep
Specialty Science
Date 2024 Mar 12
PMID 38467667
Authors
Affiliations
Soon will be listed here.
Abstract

Uric acid (UA) is associated with non-alcoholic fatty liver disease (NAFLD). However, it is unclear whether UA plays a predictive role in NAFLD prognosis. This study aimed to explore the relationship between UA levels and mortality in NAFLD patients without severe renal disease. Data were obtained from the Third National Health and Nutrition Examination Survey (NHANES). Time-dependent Cox regression was used to estimate the hazard ratio (HR) and 95% confidence interval (CI) for mortality. Overall, 2493 individuals with NAFLD and estimated glomerular filtration rate (eGFR) > 60 mL/min/1.73 m were included in this study. The median follow-up period was 26.58 years. Patients were divided into high and low-UA groups according to UA levels. Time-independent Cox regression showed that UA level was not an independent risk factor for mortality in NAFLD patients without decreased eGFR (P > 0.05). After matching for age and sex using the propensity score matching method, UA remained not independently associated with death in NAFLD patients (P > 0.05). Similar results were found for cardiovascular-related and cancer-related deaths. Although UA is closely related to NAFLD, UA levels are not independently associated with the long-term survival of patients with NAFLD without decreased eGFR.

Citing Articles

Cross-sectional study on the association between serum uric acid levels and non-alcoholic fatty liver disease in an elderly population.

Xu J, Deng M, Weng Y, Feng H, He X Sci Rep. 2025; 15(1):5678.

PMID: 39956839 PMC: 11830768. DOI: 10.1038/s41598-025-90590-3.


Distinct metabolic perturbations link liver steatosis and incident CVD in lean but not obese PWH.

van Eekeren L, Vadaq N, Blaauw M, Groenendijk A, Vos W, Nelwan E BMC Med. 2025; 23(1):78.

PMID: 39934780 PMC: 11817758. DOI: 10.1186/s12916-025-03914-5.


The relationship between serum uric acid levels and liver stiffness in patients with type II diabetes mellitus and fatty liver disease.

Yakut A Rev Assoc Med Bras (1992). 2024; 70(12):e20241013.

PMID: 39699481 PMC: 11656530. DOI: 10.1590/1806-9282.20241013.


Analysis of the association between non-alcoholic fatty liver disease and mortality in United States adults.

Rong F, Mai Y, Shou L, Zhu X, Li M, Zhu L Front Nutr. 2024; 11:1502671.

PMID: 39650715 PMC: 11620881. DOI: 10.3389/fnut.2024.1502671.

References
1.
Sun D, Wu S, Liu W, Lu Q, Zhu G, Shi K . Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. Expert Opin Ther Targets. 2015; 20(3):375-87. DOI: 10.1517/14728222.2016.1096930. View

2.
Chang D, Wang J, Chen M, Zhang L, Zhao M . Association between serum uric acid level and mortality in China. Chin Med J (Engl). 2021; 134(17):2073-2080. PMC: 8439999. DOI: 10.1097/CM9.0000000000001631. View

3.
Angulo P, Kleiner D, Dam-Larsen S, Adams L, Bjornsson E, Charatcharoenwitthaya P . Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015; 149(2):389-97.e10. PMC: 4516664. DOI: 10.1053/j.gastro.2015.04.043. View

4.
Naomi N, Ngo J, Brouwer-Brolsma E, Buso M, Soedamah-Muthu S, Perez-Rodrigo C . Sugar-sweetened beverages, low/no-calorie beverages, fruit juice and non-alcoholic fatty liver disease defined by fatty liver index: the SWEET project. Nutr Diabetes. 2023; 13(1):6. PMC: 10121594. DOI: 10.1038/s41387-023-00237-3. View

5.
Petta S, Camma C, Cabibi D, Di Marco V, Craxi A . Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011; 34(7):757-66. DOI: 10.1111/j.1365-2036.2011.04788.x. View